Use: Results are for the identification and differentiation of RNA from SARS-CoV-2, Influenza A, Influenza B and RSV.
Limitations: This assay is intended for use only under the Food and Drug Administration's Emergency Use Authorization.
Methodology: Nucleic Acid Amplification (NAA)
***This test is only available to practitioners that collect specimens in office ***